Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 18, 2001 - Issue 1
116
Views
32
CrossRef citations to date
0
Altmetric
Original

IMPAIRED MODULATION OF CIRCADIAN RHYTHMS IN PATIENTS WITH DIABETES MELLITUS: A RISK FACTOR FOR CARDIAC THROMBOTIC EVENTS?

Pages 109-121 | Received 12 May 2000, Accepted 04 Aug 2000, Published online: 07 Jul 2009

REFERENCES

  • Grundy S. M., Benjamin I. J., Burke G. L., et al. Diabetes and Cardiovascular Disease: A Statement for Healthcare Professionals from the American Heart Association. Circulation 1999; 100: 1134–46
  • American Diabetes Association. Consensus Statement: Role of Cardiovascular Risk Factors in Prevention and Treatment of Macrovascular Disease in Diabetes. Diabetes Care 1993; 16: 72–78
  • Velasco A., Huerta I., Marin B. Plasma Corticosterone, Motor Activity and Metabolic Circadian Patterns in Streptozotocin-Induced Diabetic Rats. Chronobiol. Int. 1988; 5: 127–35
  • Van Cauter E., Polonsky K. S., Scheen A. J. Roles of Circadian Rhythmicity and Sleep in Human Glucose Regulation. Endocr. Rev. 1997; 18: 716–38
  • Challet E., van Reeth O., Turek F. W. Altered Circadian Responses to Light in Streptozotocin-Induced Diabetic Mice. Am. J. Physiol. 1999; 277: E232–37
  • Muller J. E., Stone P. H., Turi Z. G., et al. Circadian Variation in the Frequency of Onset of Acute Myocardial Infarction. N. Engl. J. Med. 1985; 313: 1315–22
  • Willich S. N., Linderer T., Wegscheider K., et al. Increased Morning Incidence of Myocardial Infarction in the ISAM Study: Absence with Prior Beta-Adrenergic Blockade. ISAM Study Group. Circulation 1989; 80: 853–58
  • Tsementzis S. A., Gill J. S., Hitchcock E. R., et al. Diurnal Variation of and Activity During the Onset of Stroke. Neurosurgery 1985; 17: 901–904
  • Behar S., Reicher-Reiss H., Goldbourt U., et al. Circadian Variation in Pain Onset in Unstable Angina Pectoris. Am. J. Cardiol. 1991; 67: 91–93
  • Muller J. E., Ludmer P. L., Willich S. N., et al. Circadian Variation in the Frequency of Sudden Cardiac Death. Circulation 1987; 75: 131–38
  • Moser D. K., Stevenson W. G., Woo M. A., et al. Timing of Sudden Death in Patients with Heart Failure. J. Am. Coll. Cardiol. 1984; 24: 963–67
  • Fuster V., Badimon L., Badimon J. J., et al. The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes. Part I. N. Engl. J. Med. 1992; 326: 242–50
  • Fuster V., Badimon L., Badimon J. J., et al. The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes Part II. N. Engl. J. Med. 1992; 326: 310–18
  • Muller J. E., Abela G. S., Nesto R. W., et al. Triggers, Acute Risk Factors and Vulnerable Plaques: The Lexicon of a New Frontier. J. Am. Coll. Cardiol. 1994; 23: 809–13
  • Muller J. E., Tofler G. H., Stone P. H. Circadian Variation and Triggers of Onset of Acute Cardiovascular Disease. Circulation 1989; 79: 733–43
  • Portaluppi F., Manfredini R., Fersini C. From a Static to a Dynamic Concept of Risk: The Circadian Epidemiology of Cardiovascular Events. Chronobiol. Int. 1999; 16: 33–49
  • Furlan R., Guzzetti S., Crivellaro W., et al. Continuous 24-hour Assessment of the Neural Regulation of Systemic Arterial Pressure and RR Variabilities in Ambulant Subjects. Circulation 1990; 81: 537–47
  • Tofler G. H., Brezinski D., Schafer A. I., et al. Concurrent Morning Increase in Platelet Aggregability and the Risk of Myocardial Infarction and Sudden Cardiac Death. N. Engl. J. Med. 1987; 316: 1514–18
  • Gordon R. D., Wolfe L. K., Island D. P., et al. A Diurnal Rhythm in Plasma Renin Activity in Man. J. Clin. Invest. 1966; 45: 1587–92
  • Fujita M., Franklin D. Diurnal Changes in Coronary Blood Flow in Conscious Dogs. Circulation 1987; 76: 488–91
  • Muller J. E., Tofler G. H., Verrier R. L. Sympathetic Activity as the Cause of the Morning Increase in Cardiac Events. A Likely Culprit, but the Evidence Remains Circumstantial. Circulation 1995; 91: 2508–509
  • Lin C. S., Penha P. D., Zak F. G., et al. Morphodynamic Interpretation of Acute Coronary Thrombosis, with Special Reference to Volcano-Like Eruption of Atheromatous Plaque Caused by Coronary Artery Spasm. Angiology 1988; 39: 535–47
  • Davies M. J., Thomas A. C. Plaque Fissuring—The Cause of Acute Myocardial Infarction, Sudden Ischaemic Death, and Crescendo Angina. Br. Heart J. 1985; 53: 363–73
  • Rentrop K. P. Thrombi in Acute Coronary Syndromes: Revisited and Revised. Circulation 2000; 101: 1619–26
  • Meade T. W., Mellows S., Brozovic M., et al. Haemostatic Function and Ischaemic Heart Disease: Principal Results of the Northwick Park Heart Study. Lancet. 1986; 2: 533–37
  • Hamsten A., de Faire U., Walldius G., et al. Plasminogen Activator Inhibitor in Plasma: Risk Factor for Recurrent Myocardial Infarction. Lancet 1987; 2: 3–9
  • Trip M. D., Cats V. M., van Capelle F. J., et al. Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction. N. Engl. J. Med. 1990; 322: 1549–54
  • Thompson S. G., Kienast J., Pyke S. D., et al. Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N. Engl. J. Med. 1995; 332: 635–41
  • Andreotti F., Davies G. J., Hackett D. R., et al. Major Circadian Fluctuations in Fibrinolytic Factors and Possible Relevance to Time of Onset of Myocardial Infarction, Sudden Cardiac Death and Stroke. Am. J. Cardiol. 1988; 62: 635–37
  • Grimaudo V., Hauert J., Bachmann F., et al. Diurnal Variation of the Fibrinolytic System. Thromb. Haemost. 1988; 59: 495–99
  • Angleton P., Chandler W. L., Schmer G. Diurnal Variation of Tissue-Type Plasminogen Activator and Its Rapid Inhibitor (PAI-1). Circulation 1989; 79: 101–106
  • Brezinski D. A., Tofler G. H., Muller J. E., et al. Morning Increase in Platelet Aggregability. Association with Assumption of the Upright Posture. Circulation 1988; 78: 35–40
  • Haus E., Cusulos M., Sackett-Lundeen L., et al. Circadian Variations in Blood Coagulation Parameters, Alpha- Antitrypsin Antigen and Platelet Aggregation and Retention in Clinically Healthy Subjects. Chronobiol. Int. 1990; 7: 203–16
  • Kapiotis S., Jilma B., Quehenberger P., et al. Morning Hypercoagulability and Hypofibrinolysis. Diurnal Variations in Circulating Activated Factor VII, Prothrombin Fragment F1+2, and Plasmin-Plasmin Inhibitor Complex. Circulation 1997; 96: 19–21
  • Ehrly A. M., Jung G. Circadian Rhythm of Human Blood Viscosity. Biorheology. 1973; 10: 577–83
  • Decousus H. A., Croze M., Levi F. A., et al. Circadian Changes in Anticoagulant Effect of Heparin Infused at a Constant Rate. Br. Med. J. (Clin Res Ed). 1985; 290: 341–44
  • Fujita M., Araie E., Yamanishi K., et al. Circadian Variation in the Success Rate of Intracoronary Thrombolysis for Acute Myocardial Infarction. Am. J. Cardiol. 1993; 71: 1369–71
  • Kurnik P. B. Circadian Variation in the Efficacy of Tissue-Type Plasminogen Activator. Circulation 1995; 91: 1341–46
  • Kono T., Morita H., Nishina T., et al. Circadian Variations of Onset of Acute Myocardial Infarction and Efficacy of Thrombolytic Therapy. J. Am. Coll. Cardiol. 1996; 27: 774–78
  • Peters R. W., Muller J. E., Goldstein S., et al. Propranolol and the Morning Increase in the Frequency of Sudden Cardiac Death (BHAT Study). Am. J. Cardiol. 1989; 63: 1518–20
  • Pell S., D'Alonzo C. A. Acute Myocardial Infarction in a Large Industrial Population: Report of a 6-year Study of 1,356 Cases. JAMA 1963; 185: 831–38
  • Ulvenstam G., Aberg A., Bergstrand R., et al. Long-Term Prognosis after Myocardial Infarction in Men with Diabetes. Diabetes 1985; 34: 787–92
  • Herlitz J., Malmberg K., Karlson B. W., et al. Mortality and Morbidity during a Five-Year Follow-Up of Diabetics with Myocardial Infarction. Acta. Med. Scand. 1988; 224: 31–38
  • Gilpin E. A., Hjalmarson A., Ross J., Jr. Subgroups of Patients with Atypical Circadian Patterns of Symptom Onset in Acute Myocardial Infarction. Am. J. Cardiol. 1990; 66: 7G–11G
  • Taylor G. J., Moses H. W., Katholi R. E., et al. Six-Year Survival After Coronary Thrombolysis and Early Revascularization for Acute Myocardial Infarction. Am. J. Cardiol. 1992; 70: 26–30
  • Aronson D., Rayfield E. J., Chesebro J. H. Mechanisms Determining Course and Outcome of Diabetic Patients Who have had Acute Myocardial Infarction. Ann. Intern. Med. 1997; 126: 296–306
  • Capone R. J., Pawitan Y., el-Sherif N., et al. Events in the Cardiac Arrhythmia Suppression Trial: Baseline Predictors of Mortality in Placebo-Treated Patients. J. Am. Coll. Cardiol. 1991; 18: 1434–38
  • Stein B., Weintraub W., Gebhart S., et al. Influence of Diabetes Mellitus on Early and Late Outcome after Percutaneous Transluminal Coronary Angioplasty. Circulation 1995; 91: 979–89
  • Kip K. E., Faxon D. P., Detre K. M., et al. 1996. Coronary Angioplasty in Diabetic Patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996; 94: 1818–25
  • Ellis C. J., French J. K., White H. D., et al. Results of Percutaneous Coronary Angioplasty in Patients <40 Years of Age. Am. J. Cardiol. 1998; 82: 135–39
  • Haffner S. M., Lehto S., Ronnemaa T., et al. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. N. Engl. J. Med. 1998; 339: 229–34
  • Hjalmarson A., Gilpin E. A., Nicod P., et al. Differing Circadian Patterns of Symptom Onset in Subgroups of Patients with Acute Myocardial Infarction. Circulation 1989; 80: 267–75
  • Kleiman N. S., Schechtman K. B., Young P. M., et al. Lack of Diurnal Variation in the Onset of Non-Q Wave Infarction. Circulation 1990; 81: 548–55
  • ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Morning Peak in the Incidence of Myocardial Infarction: Experience in the ISIS-2 Trial. Eur. Heart J. 1992; 13: 594–98
  • Fava S., Azzopardi J., Muscat H. A., et al. Absence of Circadian Variation in the Onset of Acute Myocardial Infarction in Diabetic Subjects. Br. Heart J. 1995; 74: 370–72
  • Tanaka T., Fujita M., Fudo T., et al. Modification of the Circadian Variation of Symptom Onset of Acute Myocardial Infarction in Diabetes Mellitus. Coron. Artery Dis. 1995; 6: 241–44
  • Ziegler D., Dannehl K., Muhlen H., et al. Prevalence of Cardiovascular Autonomic Dysfunction Assessed by Spectral Analysis, Vector Analysis, and Standard Tests of Heart Rate Variation and Blood Pressure Responses at Various Stages of Diabetic Neuropathy. Diabet. Med. 1992; 9: 806–14
  • Kennedy W., Navarro X., Sutherland D. Neuropathy Profile of Diabetic Patients in a Pancreas Transplantation Program. Neurology 1995; 45: 773–80
  • Toyry J. P., Niskanen L. K., Mantysaari M. J., et al. Occurrence, Predictors, and Clinical Significance of Autonomic Neuropathy in NIDDM. Ten-Year Follow-Up from the Diagnosis. Diabetes 1996; 45: 308–15
  • Bernardi L., Ricordi L., Lazzari P., et al. Impaired Circadian Modulation of Sympathovagal Activity in Diabetes. A Possible Explanation for Altered Temporal Onset of Cardiovascular Disease. Circulation 1992; 86: 1443–52
  • Spallone V., Bernardi L., Ricordi L., et al. Relationship between the Circadian Rhythms of Blood Pressure and Sympathovagal Balance in Diabetic Autonomic Neuropathy. Diabetes 1993; 42: 1745–52
  • Bellavere F., Balzani I., De Masi G., et al. Power Spectral Analysis of Heart-Rate Variations Improves Assessment of Diabetic Cardiac Autonomic Neuropathy. Diabetes 1992; 41: 633–40.
  • Hoffman R. P., Sinkey C. A., Kienzle M. G., et al. Muscle Sympathetic Nerve Activity is Reduced in IDDM before Overt Autonomic Neuropathy. Diabetes 1993; 42: 375–80
  • Kreiner G., Wolzt M., Fasching P., et al. Myocardial m-[123I]iodobenzylguanidine Scintigraphy for the Assessment of Adrenergic Cardiac Innervation in Patients with IDDM. Comparison with Cardiovascular Reflex Tests and Relationship to Left Ventricular Function. Diabetes 1995; 44: 543–49
  • Aronson D., Weinrauch L., D'Elia J., et al. Circadian Patterns of Heart Rate Variability, Fibrinolytic Activity, and Hemostatic Factors in Type I Diabetes Mellitus with Cardiac Autonomic Neuropathy. Am. J. Cardiol. 1999; 84: 449–53
  • Pickering T. G., Harshfield G. A., Kleinert H. D., et al. Blood Pressure During Normal Daily Activities, Sleep, and Exercise. Comparison of Values in Normal and Hypertensive Subjects. JAMA 1982; 247: 992–96
  • O'Brien E., Sheridan J., O'Malley K. Dippers and Non-Dippers. Lancet 1988; 2: 397
  • Verdecchia P., Schillaci G., Guerrieri M., et al. Circadian Blood Pressure Changes and Left Ventricular Hypertrophy in Essential Hypertension. Circulation 1990; 81: 528–36
  • Verdecchia P., Schillaci G., Gatteschi C., et al. Blunted Nocturnal Fall in Blood Pressure in Hypertensive Women with Future Cardiovascular Morbid Events. Circulation 1993; 88: 986–92
  • Millar-Craig M. W., Bishop C. N., Raftery E. B. Circadian Variation of Blood-Pressure. Lancet 1978; 1: 795–97
  • Kohara K., Nishida W., Maguchi M., et al. Autonomic Nervous Function in Non-Dipper Essential Hypertensive Subjects. Evaluation by Power Spectral Analysis of Heart Rate Variability. Hypertension 1995; 26: 808–14
  • Mann S., Altman D. G., Raftery E. B., et al. Circadian Variation of Blood Pressure in Autonomic Failure. Circulation 1983; 68: 477–83
  • National High Blood Pressure Education Program Working Group Report on Hypertension and Diabetes. Hypertension 1994; 23: 145–58
  • American Diabetes Association. Consensus Statement on the Treatment of Hypertension in Diabetes. Diabetes Care 1993; 16: 1394–401
  • Wiegmann T. B., Herron K. G., Chonko A. M., et al. Recognition of Hypertension and Abnormal Blood Pressure Burden with Ambulatory Blood Pressure Recordings in Type I Diabetes Mellitus. Diabetes 1990; 39: 1556–60
  • Spallone V., Gambardella S., Maiello M. R., et al. Relationship between Autonomic Neuropathy, 24-h Blood Pressure Profile, and Nephropathy in Normotensive IDDM Patients. Diabetes Care 1994; 17: 578–84
  • Nielsen F. S., Rossing P., Bang L. E., et al. On the Mechanisms of Blunted Nocturnal Decline in Arterial Blood Pressure in NIDDM Patients with Diabetic Nephropathy. Diabetes 1995; 44: 783–89
  • Nakano S., Fukuda M., Hotta F., et al. Reversed Circadian Blood Pressure Rhythm is Associated with Occurrences of Both Fatal and Nonfatal Vascular Events in NIDDM Subjects. Diabetes 1998; 47: 1501–506
  • Lurbe A., Redon J., Pascual J. M., et al. Altered Blood Pressure During Sleep in Normotensive Subjects with Type I Diabetes. Hypertension 1993; 21: 227–35
  • Hansen H. P., Rossing P., Tarnow L., et al. Circadian Rhythm of Arterial Blood Pressure and Albuminuria in Diabetic Nephropathy. Kidney Int. 1996; 50: 579–85
  • Weidmann P., Beretta-Piccoli C., Trost B. N. Pressor Factors and Responsiveness in Hypertension Accompanying Diabetes Mellitus. Hypertension 1985; 7: II33–42
  • Weidmann P., Ferrari P. Central Role of Sodium in Hypertension in Diabetic Subjects. Diabetes Care 1991; 14: 220–32
  • Pickering T. G. The Clinical Significance of Diurnal Blood Pressure Variations. Dippers and Nondippers. Circulation 1990; 81: 700–702
  • Kannel W. B., RB D. A., Wilson P. W., et al. Diabetes, Fibrinogen, and Risk of Cardiovascular Disease: The Framingham Experience. Am. Heart. J. 1990; 120: 672–76
  • Stehouwer C. D., Nauta J. J., Zeldenrust G. C., et al. Urinary Albumin Excretion, Cardiovascular Disease, and Endothelial Dysfunction in Non-Insulin-Dependent Diabetes Mellitus. Lancet 1992; 340: 319–23
  • Gruden G., Cavallo-Perin P., Bazzan M., et al. PAI-1 and Factor VII Activity are Higher in IDDM Patients with Microalbuminuria. Diabetes 1994; 43: 426–29
  • Silva J. A., Escobar A., Collins T. J., et al. Unstable Angina. A Comparison of Angioscopic Findings Between Diabetic and Nondiabetic Patients. Circulation 1995; 92: 1731–36
  • Winocour P. D. Platelet Abnormalities in Diabetes Mellitus. Diabetes 41 Suppl 1992; 2: 26–31
  • Stubbs M. E., Jimenez A. H., Masahisa Y., et al. Platelet Hyperreactivity in Diabetics: Relation to Time of Onset of Acute Myocardial Infarction. J. Am. Coll. Cardiol. 1990; 15: 119A
  • Andrews N. P., Gralnick H. R., Merryman P., et al. Mechanisms Underlying the Morning Increase in Platelet Aggregation: A Flow Cytometry Study. J. Am. Coll Cardiol. 1996; 28: 1789–95
  • Malyszko J., Urano T., Knofler R., et al. Daily Variations of Platelet Aggregation in Relation to Blood and Plasma Serotonin in Diabetes. Thromb. Res. 1994; 75: 569–76
  • Pyorala K., Laakso M., Uusitupa M. Diabetes and Atherosclerosis: An Epidemiologic View. Diabetes Metab. Rev. 1987; 3: 463–524
  • Engler R. L., Yellon D. M. Sulfonylurea KATP Blockade in Type II Diabetes and Preconditioning in Cardiovascular Disease. Time for Reconsideration. Circulation 1996; 94: 2297–301
  • Garratt K. N., Brady P. A., Hassinger N. L., et al. Sulfonylurea Drugs Increase Early Mortality in Patients with Diabetes Mellitus after Direct Angioplasty for Acute Myocardial Infarction. J. Am. Coll. Cardiol. 1999; 33: 119–24
  • Juhan-Vague I., Alessi M. C., Raccah D., et al. Daytime Fluctuations of Plasminogen Activator Inhibitor 1 (PAI-1) in Populations with High PAI-1 Levels. Thromb. Haemost. 1992; 67: 76–82
  • Rosing D. R., Brakman P., Redwood D. R., et al. Blood Fibrinolytic Activity in Man. Diurnal Variation and the Response to Varying Intensities of Exercise. Circ. Res. 1970; 27: 171–84

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.